Chinese Drug Regulators Extend Rare Fast-track Approval For J&J Drug

HONG KONG - In an extremely rare case of fast-track approval for a special class of medicines, Chinese drug regulators have given the green light for a Johnson & Johnson drug to be launched nationwide before the completion of clinical trials inside China